| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Teva Pharmaceutical Industries Limited (TEVA) have been net sellers, shedding 441,824 shares worth roughly $17.0M on balance.
TEVA sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.12M | - | - | |
| CEO | 1.18M | - | - | |
| Dir | 448.0K | - | - | |
| Dir | 130.1K | - | - | |
| Dir | 127.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 12, 2018 | Stark David Matthew53 | Exec. VP Chief Legal Officer | Sale+OE | 2,441 | $19.20 | $46,867.20 | -45.1% | |
| Mar 5, 2018 | O'Grady Brendan P. | EVP, North America Commercial | Sale+OE | 705 | $19.38 | $13,662.90 | -33.7% | |
| Mar 5, 2018 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 1,108 | $19.28 | $21,362.24 | -100% | |
| Mar 5, 2018 | Griffin Deborah A | Chief Accounting Officer | Sale+OE | 773 | $19.38 | $14,980.74 | -100% | |
| Feb 15, 2018 | Sabag Mark | EVP, Global Human Resources | Sell | 5,050 | $19.68 | $99,382.50 | -10.8% |